Stem Cell Therapeutics Firm ISCO, in Clinical Trial for Parkinson’s, Reviews Key Achievements of 2016 – Parkinson’s News Today
|
Stem Cell Therapeutics Firm ISCO, in Clinical Trial for Parkinson's, Reviews Key Achievements of 2016
Parkinson’s News Today International Stem Cell Corp. (ISCO) says two of its biggest achievements in the last quarter of 2016 was demonstrating that ISC-hpNSC can improve cognitive performance and motor coordination in rodents with traumatic brain injury, and successfully … International Stem Cell Corp (ISCO) CEO Andrey Semechkin Acquires 8100 Shares International Stem Cell Corp annual loss narrows International Stem Cell Corporation Announces 2016 Fourth Quarter and Year-End Results |
